Capricor Therapeutics CAPR
NASDAQ CAPR
$9.47 +0.90 (+10.50%)
At close: Sep 30, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Interest Expenses (2013 - 2017)

Updated

Capricor Therapeutics' Interest Expenses was $3.05 million in FY2025.

Analysis

Capricor Therapeutics (CAPR) Interest Expenses (2013 - 2017) Analysis & Trends

From FY2013 onward, Capricor Therapeutics has reported Interest Expenses for 6 years.

  • The FY2025 figure marks the highest annual Interest Expenses in data going back to FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Capricor Therapeutics 550.29 Mn 550.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 80,307.00
Sep 30, 2017 107,653.00
Jun 30, 2017 105,527.00
Mar 31, 2017 105,320.00
Dec 31, 2016 102,905.00
Sep 30, 2016 98,749.00
Jun 30, 2016 76,887.00
Mar 31, 2016 66,125.00
Dec 31, 2015 63,583.00
Sep 30, 2015 61,681.00
Jun 30, 2015 61,681.00
Mar 31, 2015 61,681.00
Dec 31, 2014 60,383.00
Sep 30, 2014 60,091.00
Jun 30, 2014 54,704.00
Mar 31, 2014 25,327.00
Dec 31, 2013 24,859.00
Sep 30, 2013 23,353.00
Jun 30, 2013 6,211.00
Mar 31, 2013 3,711.00
API Access

Capricor Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CAPR&period=max&api_key=YOUR_API_KEY